Alphabet launches Isomorphic Laboratories to pursue AI-first drug discovery
Alphabet has founded Isomorphic Laboratories, a company that uses artificial intelligence to discover new medicines. It is led by Demis Hassabis, the chief executive of the DeepMind lab.